Article
Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.
Expert review of anticancer therapy - 1 Feb 2005
Newton Herbert B
Abstract excerpt
Brain tumors are a diverse group of malignancies that remain refractory to conventional treatment approaches. Molecular neuro-oncology has now begun to clarify the transformed phenotype of brain tumors and identify oncogenic pathways that might be amenable to targeted therapy. Loss of the tumor suppressor gene p53 and its encoded protein are the most common genetic events in human cancer and are a frequent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
